$ENMI
DH ENCHANTMENT, INC. Stock $enmi

$enmi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000168316823004512 Filed on June 29, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$583.00	$1.190K	$15.10K
YoY Change	-66.61%	-99.68%	-97.25%
Cost Of Revenue	$989.00	-$1.700K	$6.650K
YoY Change	-19.53%	-100.63%	-98.49%
Gross Profit	-$406.00	$2.890K	$8.450K
YoY Change	-178.53%	-97.2%	-92.26%
Gross Profit Margin	-69.64%	242.86%	55.96%
Selling, General & Admin	$3.062K	$47.10K	$384.6K
YoY Change	-98.65%	-83.43%	-29.22%
% of Gross Profit		1629.76%	4551.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$20.98K	$47.10K	$384.6K
YoY Change	-92.41%	-83.43%	-29.22%
Operating Profit	-$21.39K	-$44.21K	-$376.1K
YoY Change	-92.25%	-75.56%	-13.36%
Interest Expense	-$2.720K	-$2.690K	-$9.740K
YoY Change	72.15%	-49.63%	10.06%
% of Operating Profit
Other Income/Expense, Net	-$2.712K	-$8.930K	-$9.737K
YoY Change	-124.61%		10.1%
Pretax Income	-$24.10K	-$55.82K	-$385.9K
YoY Change	-90.9%	-70.03%	-12.89%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$24.10K	-$55.82K	-$385.9K
YoY Change	-90.9%	-70.03%	-12.89%
Net Earnings / Revenue	-4134.13%	-4690.76%	-2555.5%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	831.3M shares	831.3M shares	831.3M shares
Diluted Shares Outstanding	841.3M shares		831.3M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$280.00	$13.49K	$13.49K
YoY Change	-99.76%	-87.89%	-87.89%
Cash & Equivalents	$283.00	$13.49K	$13.49K
Short-Term Investments
Other Short-Term Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Inventory	$715.00	$1.700K	$1.700K
Prepaid Expenses
Receivables	$0.00	$30.00	$30.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$998.00	$15.22K	$15.22K
YoY Change	-99.16%	-87.47%	-87.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$998.00	$15.22K	$15.22K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$998.00	$15.22K	$15.22K
YoY Change	-99.16%	-87.47%	-87.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$452.7K	$540.5K	$540.5K
YoY Change	-16.58%	92.24%	92.24%
Deferred Revenue
YoY Change
Short-Term Debt	$133.6K	$133.6K	$133.6K
YoY Change	0.0%	0.0%	0.0%
Long-Term Debt Due	$84.22K	$84.08K	$84.08K
YoY Change	9.98%
Total Short-Term Liabilities	$847.2K	$837.1K	$837.1K
YoY Change	3.48%	74.73%	74.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$847.2K	$837.1K	$837.1K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$847.2K	$837.1K	$837.1K
YoY Change	3.48%	50.65%	50.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.682M	-$1.658M
YoY Change	9.43%	30.34%
Common Stock	$831.3K	$831.3K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$846.2K	-$821.9K	-$821.9K
YoY Change
Total Liabilities & Shareholders Equity	$998.00	$15.22K	$15.22K
YoY Change	-99.16%	-87.47%	-87.47%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$24.10K	-$55.82K	-$385.9K
YoY Change	-90.9%	-70.03%	-12.89%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$45.93K	-$22.87K	-$118.2K
YoY Change	-2162.51%	-133.25%	-31.28%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$32.86K	100.0	22.25K
YoY Change	2053.15%	-97.19%	-89.46%
NET CHANGE
Cash From Operating Activities	-$45.93K	-22.87K	-118.2K
Cash From Investing Activities
Cash From Financing Activities	$32.86K	100.0	22.25K
Net Change In Cash	-$13.21K	-22.77K	-95.99K
YoY Change	-457.37%	-131.48%	-346.0%
FREE CASH FLOW
Cash From Operating Activities	-$45.93K	-$22.87K	-$118.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001300781
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	ENMI	Conversion Of Preferred Stock ConversionOfPreferredStock		usd
CY2022	ENMI	Fractional Shares From Reverse Split FractionalSharesFromReverseSplit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56322
CY2023	dei	Entity Registrant Name EntityRegistrantName	DH ENCHANTMENT, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1415044
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Unit A, 13/F
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Gee Luen Factory Building
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	316-318 Kwun Tong Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kowloon
CY2023	dei	Entity Address Country EntityAddressCountry	HK
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2023	dei	City Area Code CityAreaCode	852
CY2023	dei	Local Phone Number LocalPhoneNumber	2621 3288
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	831310013	shares
CY2022Q3	dei	Entity Public Float EntityPublicFloat	3269790	usd
CY2023	dei	Auditor Name AuditorName	J&S Associate PLT
CY2023	dei	Auditor Firm AuditorFirmId	6743
CY2023	dei	Auditor Location AuditorLocation	Kuala Lumpur, Malaysia
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13488	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111396	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5618	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	0	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4419	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1700	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	0	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	15220	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	121433	usd
CY2023Q1	us-gaap	Assets Assets	15220	usd
CY2022Q1	us-gaap	Assets Assets	121433	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	87746	usd
CY2022Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	54779	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	452732	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226366	usd
CY2023Q1	ENMI	Amount Due To Director Current AmountDueToDirectorCurrent	78968	usd
CY2022Q1	ENMI	Amount Due To Director Current AmountDueToDirectorCurrent	64365	usd
CY2023Q1	ENMI	Promissory Notes Related Parties Current PromissoryNotesRelatedPartiesCurrent	84077	usd
CY2022Q1	ENMI	Promissory Notes Related Parties Current PromissoryNotesRelatedPartiesCurrent	0	usd
CY2023Q1	ENMI	Note Payable Related Party Current NotePayableRelatedPartyCurrent	133557	usd
CY2022Q1	ENMI	Note Payable Related Party Current NotePayableRelatedPartyCurrent	133557	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	837080	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	479067	usd
CY2023Q1	ENMI	Promissory Notes Related Parties Noncurrent PromissoryNotesRelatedPartiesNoncurrent	0	usd
CY2022Q1	ENMI	Promissory Notes Related Parties Noncurrent PromissoryNotesRelatedPartiesNoncurrent	76584	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	76584	usd
CY2023Q1	us-gaap	Liabilities Liabilities	837080	usd
CY2022Q1	us-gaap	Liabilities Liabilities	555651	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4400000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4400000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	831310013	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	831310013	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	831310013	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	831310013	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	831310	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	831310	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1701	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	64	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1657809	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1271932	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-821860	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-434218	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15220	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	121433	usd
CY2023	us-gaap	Revenues Revenues	15098	usd
CY2022	us-gaap	Revenues Revenues	548571	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	6646	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	439343	usd
CY2023	us-gaap	Gross Profit GrossProfit	8452	usd
CY2022	us-gaap	Gross Profit GrossProfit	109228	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	226366	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	226366	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5203	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	47543	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	153023	usd
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	269457	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	384592	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	543366	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-376140	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-434138	usd
CY2023	us-gaap	Unrealized Gain On Foreign Currency Derivatives Before Tax UnrealizedGainOnForeignCurrencyDerivativesBeforeTax	0	usd
CY2022	us-gaap	Unrealized Gain On Foreign Currency Derivatives Before Tax UnrealizedGainOnForeignCurrencyDerivativesBeforeTax	91	usd
CY2023	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-4	usd
CY2022	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	-1	usd
CY2023	ENMI	Interest Expense Related Parties InterestExpenseRelatedParties	9741	usd
CY2022	ENMI	Interest Expense Related Parties InterestExpenseRelatedParties	8936	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9737	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8844	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-385877	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-442982	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-385877	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-442982	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1765	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	74	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-387642	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-442908	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	831310013	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	831310013	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	831310013	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	831310013	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-385877	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-442982	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1700	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5586	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4026	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-4419	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4419	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	259333	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	279362	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-118239	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-172065	usd
CY2023	ENMI	Advance From Director AdvanceFromDirector	14603	usd
CY2022	ENMI	Advance From Director AdvanceFromDirector	478	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	133557	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	57326	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	77052	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	49682	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	-0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22247	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	211087	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1916	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-394	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-97908	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38628	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111396	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72768	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13488	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111396	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	8690	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	74	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-442982	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-434218	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-1765	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-385877	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-821860	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_808_eus-gaap--NatureOfOperations_zi4KbCIcUIT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. <span id="xdx_825_zg7kfXE3V349">DESCRIPTION OF BUSINESS AND ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DH Enchantment, Inc. (the “Company”) was incorporated in the State of Nevada on July 9, 2004 under the name Amerivestors, Inc. On March 3, 2009, the Company changed its name to Gust Engineering & Speed Productions, Inc. and on February 1, 2011, the Company changed its name to Energy Management International, Inc. On August 11, 2021, the Company changed its name to DH Enchantment, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Currently, the Company through its subsidiaries, mainly engages with the sale and distribution of COVID-19 rapid antigen tester set. This business was commenced its operation in Hong Kong since October 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 26, 2021, the Company consummated the Share Exchange Transaction (the “Share Exchange”) among DH Investment Group Limited (“DHIG”) and its shareholders. The Company acquired all of the issued and outstanding shares of DHIG from DHIG’s shareholders, in exchange for 100,000 shares of Series B preferred stock, at par value of $0.001. Upon completion of the Share Exchange, DHIG became a <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20210726__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DHEnchantmentMember_zHHqFA8REb" title="Ownership percentage">100</span>% owned subsidiary of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Share Exchange, the Company was considered as a shell company due to its nominal assets and limited operation. The transaction will be treated as a recapitalization of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon the Share Exchange between the Company and DHIC on July 26, 2021, is a merger of entities under common control that Miss Sally Kin Yi LO is the common director and shareholder of both the Company and DHIG. Under the guidance in ASC 805 for transactions between entities under common control, the assets, liabilities and results of operations, are recognized at their carrying amounts on the date of the Share Exchange, which required retrospective combination of the Company and DHIG for all periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 29, 2021, the Company authorized and approved the amendment and restatement of our Articles of Incorporation to: (i) change our name to DH Enchantment Inc.; and (ii) amend the powers, rights and designation of the Series A Convertible Preferred Stock as more fully set forth below; and (iii) effectuate a <span id="xdx_907_eus-gaap--StockholdersEquityReverseStockSplit_c20210628__20210629_z8XKbXw4Pvxd" title="Reverse stock split, description">5:1 reverse split</span>, all of which are subject to final authorization by FINRA. The Company also approved the designation of <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20210629__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zHwQu9UE5KX2" title="Preferred stock, shares authorized">10,000,000</span> shares of Series B Convertible Preferred Stock which took effect immediately.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the amendment, holders of the Series A Convertible Preferred Stock will not be: (i) entitled to receive dividends or other distributions; (ii) vote on matters submitted to a vote of the stockholders; and (iii) able to convert the Series A Convertible Preferred Stock into common stock or any other securities of the corporation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 16, 2021, the Company effected a <span id="xdx_909_eus-gaap--StockholdersEquityReverseStockSplit_c20210815__20210816_zDf4eLs4qEo6" title="Reverse stock split, description">5 for 1 reverse split</span> of its issued and outstanding shares of common stock. Except for shares authorized, all references to number of shares and per share information have been retroactively adjusted to reflect such split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Description of subsidiaries</span></p> <table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--DescriptionOfSubsidiariesTableTextBlock_zPncflNPsWz" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Details)"> <tr style="vertical-align: top"> <td> <span id="xdx_8B9_zmGE0uT0mULk" style="display: none">Schedule of description of subsidiaries</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 18%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Place of incorporation</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and kind of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">legal entity</p></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 21%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Principal activities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and place of operation</p></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particulars of registered/ paid up share capital</span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 10%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">interest held</p></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--NameOfSubsidiary_c20220401__20230331__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Name of subsidiary">DH Investment Group Limited (“DHIG”)</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--PlaceOfIncorporation_c20220401__20230331__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Place of incorporation">British Virgin Islands</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--PrincipalActivities_c20220401__20230331__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Principal activities">Investment holding</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareCapital_c20220401__20230331__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Share capital">100 ordinary shares at par value of US$1</span></span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DHInvestmentGroupLimitedMember_zTbiMWCrrbMb" title="Ownership percentage">100</span>%</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--NameOfSubsidiary_c20220401__20230331__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Name of subsidiary">Ho Shun Yi Limited (“HSYL”)</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--PlaceOfIncorporation_c20220401__20230331__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Place of incorporation">Hong Kong</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalActivities_c20220401__20230331__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Principal activities">Sale and distribution of COVID-19 rapid antigen tester set</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareCapital_c20220401__20230331__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Share capital">10,000 ordinary shares for HK$10,000</span></span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HoShunYiLimitedMember_zs85Xl4Qd2ni" title="Ownership percentage">100</span>%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiaries are hereinafter referred to as (the “Company”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2021Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	5:1 reverse split
CY2021Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	5 for 1 reverse split
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zYSd0Y3Skohh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify"><span style="font-family: Wingdings">l</span><span style="font-family: Times New Roman, Times, Serif"> <span id="xdx_86A_zbc8L6V0Lc2b">Use of estimates and assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the years reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-385877	usd
CY2023Q1	ENMI	Working Capital WorkingCapital	-821860	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	226366	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	226366	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4400000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4400000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Unit Outstanding CommonUnitOutstanding	831310013	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-385877	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-442982	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	831310013	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	831310013	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	831310013	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	831310013	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-40969	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-442982	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.165	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6760	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-73092	usd
CY2023	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	685	usd
CY2022	us-gaap	Income Tax Reconciliation Deductions IncomeTaxReconciliationDeductions	56176	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	6075	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	16916	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	164846	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	86466	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	164846	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	86466	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Pension Expense PensionExpense	0	usd
CY2022	us-gaap	Pension Expense PensionExpense	2504	usd

Files In Submission

Name	View Source	Status
0001683168-23-004512-index-headers.html	Edgar Link	pending
0001683168-23-004512-index.html	Edgar Link	pending
0001683168-23-004512.txt	Edgar Link	pending
0001683168-23-004512-xbrl.zip	Edgar Link	pending
dh_ex3101.htm	Edgar Link	pending
dh_ex3201.htm	Edgar Link	pending
dh_i10k-033123.htm	Edgar Link	pending
enmi-20230331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
enmi-20230331_def.xml	Edgar Link	unprocessable
enmi-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dh_i10k-033123_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
enmi-20230331_pre.xml	Edgar Link	unprocessable
enmi-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENMI
DH ENCHANTMENT, INC. Stock $enmi

2023 Q2 Form 10-K Financial Statement

#000168316823004512 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENMI DH ENCHANTMENT, INC. Stock $enmi

2023 Q2 Form 10-K Financial Statement

#000168316823004512 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENMI
DH ENCHANTMENT, INC. Stock $enmi